435 related articles for article (PubMed ID: 31421263)
1. Extracellular vesicles in cancer nanomedicine.
Tarasov VV; Svistunov AA; Chubarev VN; Dostdar SA; Sokolov AV; Brzecka A; Sukocheva O; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():212-225. PubMed ID: 31421263
[TBL] [Abstract][Full Text] [Related]
2. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
[TBL] [Abstract][Full Text] [Related]
4. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
[TBL] [Abstract][Full Text] [Related]
5. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.
Geng T; Pan P; Leung E; Chen Q; Chamley L; Wu Z
Pharm Res; 2021 Feb; 38(2):179-197. PubMed ID: 33604783
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
7. Cancer therapy based on extracellular vesicles as drug delivery vehicles.
Cabeza L; Perazzoli G; Peña M; Cepero A; Luque C; Melguizo C; Prados J
J Control Release; 2020 Nov; 327():296-315. PubMed ID: 32814093
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicle-based drug delivery systems for cancer treatment.
Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.
Kotmakçı M; Bozok Çetintaş V
J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135
[TBL] [Abstract][Full Text] [Related]
12. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles for tumor targeting delivery based on five features principle.
Yong T; Wang D; Li X; Yan Y; Hu J; Gan L; Yang X
J Control Release; 2020 Jun; 322():555-565. PubMed ID: 32246977
[TBL] [Abstract][Full Text] [Related]
14. Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.
Armstrong JP; Holme MN; Stevens MM
ACS Nano; 2017 Jan; 11(1):69-83. PubMed ID: 28068069
[TBL] [Abstract][Full Text] [Related]
15. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
Moosavian SA; Bianconi V; Pirro M; Sahebkar A
Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer.
Kugeratski FG; McAndrews KM; Kalluri R
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33411885
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles in the Development of Cancer Therapeutics.
Sun H; Burrola S; Wu J; Ding WQ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles.
Bai YT; Zhang XQ; Chen XJ; Zhou G
Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
